Regentis Biomaterials Ltd. (RGNT)

Regentis Biomaterials will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$10.00 - $12.00

Shares Offered

909,090

Deal Size

$10.00M

Regentis Biomaterials Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	53	-	-
Enterprise Value	56	-	-
Debt / Equity Ratio	-0.07	-0.17	-0.15
Debt / EBITDA Ratio	0.31	-3.94	-4.60
Debt / FCF Ratio	-5.86	-6.24	-4.30
Quick Ratio	0.16	0.11	0.48
Interest Coverage	3.92	-0.88	-33.50
Return on Equity (ROE)	-16.44%	9.00%	3.44%
Return on Assets (ROA)	-	-1147.78%	-84.39%
Return on Capital (ROIC)	-3.19%	5.04%	3.95%
Return on Capital Employed (ROCE)	-768.95%	69.49%	157.74%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).